Ken Warrington
Patrimonio netto: 22 361 $ in data 30/06/2026
Patrimonio netto: 22 361 $ in data 30/06/2026
Ken Warrington is currently Director at BioStem Technologies, Inc. since 2022, with employment at the company starting in 2019.
Former roles include Chief Technology Officer at Lacerta Therapeutics, Inc. from 2017 to 2019, Head-Strategy & Innovations at Genscript Probio Usa, Inc. from 2020 to 2021, and Senior VP-Operations & Business Development at Biostem Life Sciences, Inc. from 2019 to 2020.
Education includes a doctorate from the University of Florida conferred in 2000 and an undergraduate degree from The St. Lawrence College conferred in 1993.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 30/09/2025 | 6.776 ( 0,04% ) | 22 361 $ | 30/06/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| BIOSTEM TECHNOLOGIES, INC. | Direttore/Membro del Consiglio | 01/03/2022 |
| Società | Posizione | Fine |
|---|---|---|
GENSCRIPT PROBIO USA INC.
GENSCRIPT PROBIO USA INC. Genscript Probio Usa, Inc. is a private company based in Pennington, NJ. The company was founded in 2017. | Corporate Officer/Principal | 01/12/2021 |
Biostem Life Sciences, Inc. | Direttore operativo | 01/05/2020 |
Lacerta Therapeutics, Inc.
Lacerta Therapeutics, Inc. BiotechnologyHealth Technology Operates as biotechnology company | Direttore Tecnico/Scientifico/R&S | 01/05/2019 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 6 |
|---|---|
University of Florida
University of Florida Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BioStem Technologies, Inc.
BioStem Technologies, Inc. BiotechnologyHealth Technology Develops stem cell based medical therapies | Health Technology |
The St. Lawrence College
The St. Lawrence College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lacerta Therapeutics, Inc.
Lacerta Therapeutics, Inc. BiotechnologyHealth Technology Operates as biotechnology company | Health Technology |
GENSCRIPT PROBIO USA INC.
GENSCRIPT PROBIO USA INC. Genscript Probio Usa, Inc. is a private company based in Pennington, NJ. The company was founded in 2017. | |
Biostem Life Sciences, Inc. |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale